Browse the evidence

GIP receptor (GIPR) antagonism prevents diet-induced obesity and reduces fat mass in mice and non-human primates, independent of pancreatic beta-cell GIPR activity.

Blocking the GIP receptor appears to be a powerful strategy for weight loss in preclinical models, working by reducing food intake and increasing fat burning (lipid oxidation). This effect is independent of how the pancreas handles insulin, suggesting a direct metabolic benefit. When combined with existing GLP-1 drugs (like semaglutide or liraglutide), weight loss is significantly enhanced, suggesting these mechanisms can be stacked for greater efficacy.

GIPR antagonism reduces the Respiratory Exchange Ratio (RER) during rest, indicating increased lipid oxidation as a mechanism for weight loss.

Blocking GIP receptors may help your body burn more fat for fuel while at rest, even without changing your activity level. This metabolic shift contributes to the overall weight loss observed.

Obesity is metabolically heterogeneous, distinguished by metabolically unhealthy obese (MUHO) phenotypes exhibiting insulin resistance, inflammation, and altered metabolite profiles, versus metabolically healthy obese (MHO) phenotypes.

Do not assume that a high BMI automatically implies poor metabolic health or high disease risk. Metabolically Healthy Obesity (MHO) exists, but Metabolically Unhealthy Obesity (MUHO) carries specific risks like insulin resistance and inflammation. To understand your actual health risk, metabolic markers (like blood sugar, lipids, and inflammation) must be tested, as BMI alone is insufficient.

Sleep irregularity is associated with increased perceived stress and depressive symptoms, which may serve as additional mechanisms linking irregular sleep to cardiometabolic disease.

Recognize that mental health and sleep consistency are linked. If you are experiencing high stress or depressive symptoms, improving your sleep regularity (consistent bed/wake times) may help alleviate these symptoms and reduce your long-term risk of cardiovascular disease.

Tirzepatide improves systemic insulin sensitivity in obese mice through a weight-independent mechanism mediated by GIP receptor (GIPR) agonism, which enhances glucose disposal in white adipose tissue and upregulates BCAA catabolism in brown adipose tissue.

Tirzepatide improves how your body handles sugar through two paths: losing weight and directly activating receptors in your fat tissue to burn glucose and amino acids more efficiently. This dual action means it can improve blood sugar control even if weight loss is modest.

Activation of PPARγ by thiazolidinediones (TZDs) like pioglitazone and rosiglitazone improves insulin sensitivity and glucose homeostasis, primarily by promoting fatty acid storage in adipose tissue and enhancing glucose uptake in skeletal muscle.

TZDs like pioglitazone activate PPARγ to help your body handle sugar better. They work by moving fat storage to your皮下 fat (subcutaneous) rather than your liver and muscles, which reduces insulin resistance. This improves blood sugar control but may lead to weight gain.

As food systems transition from rural/traditional to industrial/consolidated, the affordability of a recommended nutritious diet improves significantly, yet industrial systems fail to deliver optimal nutrition, environmental sustainability, and equity.

Do not assume that simply having the money to buy a 'healthy' diet guarantees good health outcomes. In industrialized food systems, while you can afford the recommended diet, the actual quality, environmental impact, and equity of that food supply may still be suboptimal. Focus on the quality and source of food, not just its cost.

As income and food system industrialization increase, per capita supply of animal-source foods increases, while supply of pulses and coarse grains decreases.

As your income rises, you may naturally gravitate towards more animal proteins and away from pulses and coarse grains. Be aware that this shift is a common economic trend, not necessarily a nutritional improvement. Pulses and coarse grains remain valuable, nutrient-dense components of a balanced diet.

Insulin resistance promotes atherosclerosis through impaired insulin signaling (specifically reduced PI-3 kinase activation) which decreases nitric oxide production, leading to endothelial dysfunction and accelerated plaque progression, independent of hyperglycemia.

If you have insulin resistance or obesity, your cardiovascular risk is elevated even if your blood sugar is normal. Focus on improving insulin sensitivity through lifestyle changes rather than just monitoring glucose levels, as high insulin itself drives arterial damage.

Chronic hyperglycemia accelerates atherosclerosis through three distinct mechanisms: formation of advanced glycation end products (AGEs) that modify LDL, increased oxidative stress reducing nitric oxide, and pathologic activation of Protein Kinase C (PKC).

High blood sugar damages arteries through multiple pathways, including modifying LDL particles and increasing oxidative stress. Managing glucose is important, but it is only one part of the equation; insulin resistance and lipid management are equally critical.

Inflammation is involved in every step of the atherosclerotic process, from initial lipid retention to plaque destabilization, mediated by both innate (macrophages, TLRs) and adaptive (T cells, B cells) immune responses.

Inflammation drives every stage of heart disease, from the initial buildup of plaque to the rupture that causes heart attacks. Managing inflammation through lifestyle and potentially targeted therapies is crucial for preventing cardiovascular events, not just lowering cholesterol.

Female gender is a significant independent risk factor for poor sleep quality during pandemic lockdowns.

Women may be biologically more vulnerable to sleep disruption during high-stress periods. If you are female, be extra vigilant about sleep hygiene and stress management, as your baseline risk for sleep issues is higher than men's in similar circumstances.

Intranasal insulin administration improves memory and cognitive function in patients with mild cognitive impairment (MCI) and early Alzheimer's disease, particularly in non-ApoE4 carriers and women.

If you have early memory issues or MCI, ask your doctor about intranasal insulin. It is a nasal spray that may help improve memory and attention without causing low blood sugar. This treatment seems to work best for women and those who do not carry the ApoE4 gene variant. It is not a cure, but it may help manage symptoms.

Peripheral metabolic dysregulation (obesity, diabetes) leads to brain insulin resistance and Alzheimer's pathology through BBB permeabilization, neuroinflammation, and AGE-RAGE signaling.

Managing your weight, blood sugar, and metabolic health is crucial for brain health. Obesity and diabetes increase the risk of Alzheimer's by causing inflammation and insulin resistance in the brain. Focus on a healthy diet and exercise to protect your brain.

Six weeks of supervised endurance exercise alters gut microbiome composition (increasing Akkermansia, decreasing Proteobacteria) and function in overweight women, but these changes do not translate into significant systemic metabolic improvements or major body composition changes.

If you are an overweight woman doing 6 weeks of endurance exercise, expect your gut bacteria to shift (more Akkermansia, less Proteobacteria) and your fitness to improve, but do not expect significant weight loss or major metabolic changes unless you also adjust your diet. The gut changes are real but may not immediately impact your blood work or scale weight.

Adiposity (body fat percentage) does not significantly modify the acute or chronic appetite and energy intake responses to exercise, meaning exercise is equally effective for appetite regulation in lean and overweight/obese individuals.

Your body weight does not determine how well exercise works for regulating your appetite. Whether you are lean or have overweight/obesity, exercise will similarly suppress your appetite temporarily and not trigger compensatory overeating. This makes exercise a universally applicable tool for energy balance.

Sleeve Gastrectomy (SG) is associated with higher T2DM relapse rates and less sustained glycemic control compared to Roux-en-Y Gastric Bypass (RYGB) over a 5-year period.

If you have already had Sleeve Gastrectomy (SG) and achieved diabetes remission, be aware that the risk of diabetes returning (relapse) is higher compared to those who had Gastric Bypass (RYGB). Regular monitoring of your blood sugar is crucial, as SG may not sustain remission as effectively as RYGB in the long term.

Evidence regarding the impact of workplace physical activity and nutrition interventions on productivity is limited and insufficient.

Employers should be cautious when expecting significant productivity gains from workplace health interventions, as the current evidence base is limited and insufficient.

Low energy availability causes a 'sick euthyroid' profile with decreased T3 and increased reverse T3, reducing energy expenditure as an adaptive response.

Low energy intake can lower your T3 levels as a way to conserve energy. This is a normal adaptation, not necessarily a thyroid disease. Focus on eating enough to support your activity level, which should normalize your thyroid hormones.

There is a curvilinear (inverted-U) relationship between GDP per capita and BMI: weight gain increases with development in low-income countries but decreases or levels off in high-income countries.

In developing economies, rising wealth often leads to higher obesity rates due to dietary changes. However, as countries become wealthier, these rates tend to stabilize or decrease, suggesting that long-term development can improve health outcomes.

Women's empowerment is positively associated with increased BMI, particularly in high-income countries.

As women gain more social and economic empowerment, there may be an increase in obesity rates due to lifestyle changes. Policymakers should ensure that healthy food options are accessible and convenient for working women.

COVID-19 pandemic lockdown restrictions significantly increase total sedentary behavior (SB) in university students, with increases averaging 1.93 hours per day on weekdays and 1.30 hours per day on weekends compared to pre-pandemic baselines.

Lockdowns and remote work/study environments naturally increase sedentary time by nearly 2 hours daily. To counteract this, you must intentionally schedule non-sedentary activities (e.g., walking meetings, standing desks, or home workouts) because the default environment will pull you toward sitting.

Female university students spend significantly more total time on sedentary behavior than male students during pandemic restrictions, with females averaging 14.19 hours/day on weekdays and 15.22 hours/day on weekends compared to males' 12.90 and 14.10 hours respectively.

Women in lockdown environments tend to accumulate more sedentary time than men. If you are female, be extra vigilant about scheduling movement, as you may be more susceptible to the sedentary pull of remote work/study environments.

During the luteal phase of the menstrual cycle, healthy women exhibit significantly reduced plasma levels of amino acids and lipids, indicating an anabolic state driven by progesterone that increases metabolic vulnerability to conditions like PMS and PMDD.

If you experience PMS or PMDD symptoms, your body is likely in a metabolically demanding 'anabolic' state during the luteal phase (post-ovulation) where amino acids and lipids are being utilized for tissue preparation. This creates a window of vulnerability. While this paper does not prescribe a specific diet, it suggests that ensuring sufficient protein and nutrient intake during this phase may help support the body's increased metabolic demands and potentially mitigate symptoms.